Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).
Takeda Y, Sakuma I, Hiramitsu S, Okada M, Ueda S, Sakurai M. Takeda Y, et al. Among authors: ueda s. Front Cardiovasc Med. 2023 Mar 16;10:1172664. doi: 10.3389/fcvm.2023.1172664. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37008309 Free PMC article.
Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan.
Takeda Y, Sakuma I, Hiramitsu S, Okada M, Ueda S, Sakurai M. Takeda Y, et al. Among authors: ueda s. BMJ Open. 2022 Nov 14;12(11):e061360. doi: 10.1136/bmjopen-2022-061360. BMJ Open. 2022. PMID: 36375977 Free PMC article.
The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).
Takeda Y, Sakuma I, Hiramitsu S, Okada M, Ueda S, Sakurai M. Takeda Y, et al. Among authors: ueda s. Front Cardiovasc Med. 2023 Jan 25;10:1094100. doi: 10.3389/fcvm.2023.1094100. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36760560 Free PMC article.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Fujii H, Fujii M, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Tsutsumi T, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: ueda s. Hepatol Res. 2023 May;53(5):391-400. doi: 10.1111/hepr.13884. Epub 2023 Feb 17. Hepatol Res. 2023. PMID: 36707103
3,103 results